NASDAQ: IBIOIbio Inc Stock Ownership - Who owns Ibio?
Insider buying vs selling
Have Ibio Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| David Arkowitz | Director | 2025-01-10 | 18,382 | $2.72 | $50.00kBuy |
| Marc Banjak | Chief Legal Officer | 2025-01-10 | 9,191 | $2.72 | $25.00kBuy |
| Martin Brenner | Chief Executive Officer and Chief Scientific Officer | 2025-01-10 | 9,191 | $2.72 | $25.00kBuy |
| William D. 1. Clark | Director | 2025-01-10 | 1,838 | $2.72 | $5.00kBuy |
| Felipe Duran | Chief Financial Officer | 2025-01-10 | 9,191 | $2.72 | $25.00kBuy |
| Antonio Bernardino Guimaraes Parada | Director | 2025-01-10 | 183,823 | $2.72 | $500.00kBuy |
| Gary Sender | Director | 2025-01-10 | 9,191 | $2.72 | $25.00kBuy |
IBIO insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when IBIO insiders and whales buy or sell their stock.
IBIO Shareholders
What type of owners hold Ibio Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| E. Gerald Kay | 149.64% | 14,776,201 | $13.58M | Insider |
| Eastern Capital Ltd | 87.39% | 8,629,693 | $7.93M | Insider |
| Carl Desantis | 58.24% | 5,751,143 | $5.29M | Insider |
| John D. McKey Jr. | 23.17% | 2,288,133 | $2.10M | Insider |
| Thomas Francis 3rd Isett | 12.91% | 1,275,000 | $1.17M | Insider |
| Robert Kay | 10.44% | 1,030,962 | $947.45k | Insider |
| Lynx1 Capital Management LP | 8.73% | 862,279 | $792.43k | Institution |
| Ikarian Capital LLC | 6.08% | 599,913 | $551.32k | Institution |
| Adar1 Capital Management LLC | 4.21% | 415,606 | $381.94k | Institution |
| Opaleye Management Inc | 3.80% | 375,000 | $344.63k | Institution |
IBIO vs Biotech Stocks
Ibio Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.